Jake Lebiecki is a seasoned pharmaceutical professional with over 14 years of expertise in Pricing & Reimbursement (P&R) policy, market access, and Health Economics and Outcomes Research (HEOR). Currently serving as the Senior Director of Global Access Strategy & Pricing Lead for the Oncology Lung Franchise at Pfizer, they provide strategic leadership on market access initiatives and influential policy development. Prior to their role at Pfizer, Jake held positions at WG Consulting, RTI Health Solutions, and GlaxoSmithKline, where they contributed to market access and outcomes strategy. They earned both a PhD in Neurobiology and Neurosciences and a BSc in Biochemistry from The University of Manchester.
This person is not in any teams
This person is not in any offices